192 related articles for article (PubMed ID: 29168174)
1. Genetic variants in the platelet-derived growth factor subunit B gene associated with pancreatic cancer risk.
Duan B; Hu J; Liu H; Wang Y; Li H; Liu S; Xie J; Owzar K; Abbruzzese J; Hurwitz H; Gao H; Wei Q
Int J Cancer; 2018 Apr; 142(7):1322-1331. PubMed ID: 29168174
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants of the peroxisome proliferator-activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer.
Liu X; Qian D; Liu H; Abbruzzese JL; Luo S; Walsh KM; Wei Q
Mol Carcinog; 2020 Aug; 59(8):930-939. PubMed ID: 32367578
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in the liver kinase B1-AMP-activated protein kinase pathway genes and pancreatic cancer risk.
Xu X; Qian D; Liu H; Cruz D; Luo S; Walsh KM; Abbruzzese JL; Zhang X; Wei Q
Mol Carcinog; 2019 Aug; 58(8):1338-1348. PubMed ID: 30997723
[TBL] [Abstract][Full Text] [Related]
4. Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer risk.
Yang W; Liu H; Duan B; Xu X; Carmody D; Luo S; Walsh KM; Abbruzzese JL; Zhang X; Chen X; Wei Q
Cancer Sci; 2019 Jun; 110(6):2022-2032. PubMed ID: 30972876
[TBL] [Abstract][Full Text] [Related]
5. Potential functional variants in SMC2 and TP53 in the AURORA pathway genes and risk of pancreatic cancer.
Feng Y; Liu H; Duan B; Liu Z; Abbruzzese J; Walsh KM; Zhang X; Wei Q
Carcinogenesis; 2019 Jun; 40(4):521-528. PubMed ID: 30794721
[TBL] [Abstract][Full Text] [Related]
6. Platelet Derived Growth Factor-B and Human Epidermal Growth Factor Receptor-2 Polymorphisms in Gall Bladder Cancer.
Mishra K; Behari A; Kapoor VK; Khan MS; Prakash S; Agrawal S
Asian Pac J Cancer Prev; 2015; 16(14):5647-54. PubMed ID: 26320430
[TBL] [Abstract][Full Text] [Related]
7. Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets.
Chen J; Wu X; Huang Y; Chen W; Brand RE; Killary AM; Sen S; Frazier ML
Oncotarget; 2016 Aug; 7(35):56480-56490. PubMed ID: 27486767
[TBL] [Abstract][Full Text] [Related]
8. Associations between genetic variants of KIF5B, FMN1, and MGAT3 in the cadherin pathway and pancreatic cancer risk.
Zhao L; Liu H; Luo S; Moorman PG; Walsh KM; Li W; Wei Q
Cancer Med; 2020 Dec; 9(24):9620-9631. PubMed ID: 33200553
[TBL] [Abstract][Full Text] [Related]
9. rs1859168 A > C polymorphism regulates HOTTIP expression and reduces risk of pancreatic cancer in a Chinese population.
Hu P; Qiao O; Wang J; Li J; Jin H; Li Z; Jin Y
World J Surg Oncol; 2017 Aug; 15(1):155. PubMed ID: 28818070
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in Hippo signalling pathway-related genes affect the risk of colorectal cancer.
Shen H; Meng Y; Hu T; Li S; Du M; Xin J; Gu D; Wang M; Fu Z
Arch Toxicol; 2021 Jan; 95(1):271-281. PubMed ID: 33011827
[TBL] [Abstract][Full Text] [Related]
11. The platelet derived growth factor-B polymorphism is associated with risk of severe fever with thrombocytopenia syndrome in Chinese individuals.
Zhang XA; Guo CT; Lu QB; Hu JG; Cui N; Yang ZD; Peng W; Liu R; Hu CY; Qin SL; Wang XJ; Ding SJ; Huang DD; Liu W; Cao WC
Oncotarget; 2016 May; 7(22):33340-9. PubMed ID: 27147565
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide analysis of expression quantitative trait loci identified potential lung cancer susceptibility variants among Asian populations.
Fan J; Zhu M; Wang Y; Li Z; Zhang J; Wang L; Sun Q; Dai J; Jin G; Hu Z; Shen H; Ma H
Carcinogenesis; 2019 Apr; 40(2):263-268. PubMed ID: 30689816
[TBL] [Abstract][Full Text] [Related]
13. A single nucleotide polymorphism in the 3'-UTR of STAT3 regulates its expression and reduces risk of pancreatic cancer in a Chinese population.
Zhu B; Zhu Y; Lou J; Ke J; Zhang Y; Li J; Gong Y; Yang Y; Tian J; Peng X; Zou D; Zhong R; Gong J; Chang J; Li L; Miao X
Oncotarget; 2016 Sep; 7(38):62305-62311. PubMed ID: 27577070
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants of genes in the NER pathway associated with risk of breast cancer: A large-scale analysis of 14 published GWAS datasets in the DRIVE study.
Ge J; Liu H; Qian D; Wang X; Moorman PG; Luo S; Hwang S; Wei Q
Int J Cancer; 2019 Sep; 145(5):1270-1279. PubMed ID: 31026346
[TBL] [Abstract][Full Text] [Related]
15. Association of XRCC1 gene single nucleotide polymorphisms and susceptibility to pancreatic cancer in Chinese.
Chen H; Tang C; Liu M; Zhou B; Kuang Y; Yuan T; Chen P
Tumour Biol; 2014 Jan; 35(1):27-32. PubMed ID: 23893380
[TBL] [Abstract][Full Text] [Related]
16. A functional variant rs1537373 in 9p21.3 region is associated with pancreatic cancer risk.
Zhu B; Zhu Y; Tian J; Shen N; Li J; Lou J; Ke J; Yang Y; Gong Y; Gong J; Chang J; Miao X; Zhong R
Mol Carcinog; 2019 May; 58(5):760-766. PubMed ID: 30604909
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in glutamine metabolic pathway genes predict cutaneous melanoma-specific survival.
Chen K; Liu H; Liu Z; Bloomer W; Amos CI; Lee JE; Li X; Nan H; Wei Q
Mol Carcinog; 2019 Nov; 58(11):2091-2103. PubMed ID: 31435991
[TBL] [Abstract][Full Text] [Related]
18. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21.
Zhang M; Wang Z; Obazee O; Jia J; Childs EJ; Hoskins J; Figlioli G; Mocci E; Collins I; Chung CC; Hautman C; Arslan AA; Beane-Freeman L; Bracci PM; Buring J; Duell EJ; Gallinger S; Giles GG; Goodman GE; Goodman PJ; Kamineni A; Kolonel LN; Kulke MH; Malats N; Olson SH; Sesso HD; Visvanathan K; White E; Zheng W; Abnet CC; Albanes D; Andreotti G; Brais L; Bueno-de-Mesquita HB; Basso D; Berndt SI; Boutron-Ruault MC; Bijlsma MF; Brenner H; Burdette L; Campa D; Caporaso NE; Capurso G; Cavestro GM; Cotterchio M; Costello E; Elena J; Boggi U; Gaziano JM; Gazouli M; Giovannucci EL; Goggins M; Gross M; Haiman CA; Hassan M; Helzlsouer KJ; Hu N; Hunter DJ; Iskierka-Jazdzewska E; Jenab M; Kaaks R; Key TJ; Khaw KT; Klein EA; Kogevinas M; Krogh V; Kupcinskas J; Kurtz RC; Landi MT; Landi S; Le Marchand L; Mambrini A; Mannisto S; Milne RL; Neale RE; Oberg AL; Panico S; Patel AV; Peeters PH; Peters U; Pezzilli R; Porta M; Purdue M; Quiros JR; Riboli E; Rothman N; Scarpa A; Scelo G; Shu XO; Silverman DT; Soucek P; Strobel O; Sund M; Małecka-Panas E; Taylor PR; Tavano F; Travis RC; Thornquist M; Tjønneland A; Tobias GS; Trichopoulos D; Vashist Y; Vodicka P; Wactawski-Wende J; Wentzensen N; Yu H; Yu K; Zeleniuch-Jacquotte A; Kooperberg C; Risch HA; Jacobs EJ; Li D; Fuchs C; Hoover R; Hartge P; Chanock SJ; Petersen GM; Stolzenberg-Solomon RS; Wolpin BM; Kraft P; Klein AP; Canzian F; Amundadottir LT
Oncotarget; 2016 Oct; 7(41):66328-66343. PubMed ID: 27579533
[TBL] [Abstract][Full Text] [Related]
19. Rs488087 single nucleotide polymorphism as predictive risk factor for pancreatic cancers.
Martinez E; Silvy F; Fina F; Bartoli M; Krahn M; Barlesi F; Figarella-Branger D; Iovanna J; Laugier R; Ouaissi M; Lombardo D; Mas E
Oncotarget; 2015 Nov; 6(37):39855-64. PubMed ID: 26498142
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer.
Lin Y; Nakatochi M; Hosono Y; Ito H; Kamatani Y; Inoko A; Sakamoto H; Kinoshita F; Kobayashi Y; Ishii H; Ozaka M; Sasaki T; Matsuyama M; Sasahira N; Morimoto M; Kobayashi S; Fukushima T; Ueno M; Ohkawa S; Egawa N; Kuruma S; Mori M; Nakao H; Adachi Y; Okuda M; Osaki T; Kamiya S; Wang C; Hara K; Shimizu Y; Miyamoto T; Hayashi Y; Ebi H; Kohmoto T; Imoto I; Kasugai Y; Murakami Y; Akiyama M; Ishigaki K; Matsuda K; Hirata M; Shimada K; Okusaka T; Kawaguchi T; Takahashi M; Watanabe Y; Kuriki K; Kadota A; Okada R; Mikami H; Takezaki T; Suzuki S; Yamaji T; Iwasaki M; Sawada N; Goto A; Kinoshita K; Fuse N; Katsuoka F; Shimizu A; Nishizuka SS; Tanno K; Suzuki K; Okada Y; Horikoshi M; Yamauchi T; Kadowaki T; Yu H; Zhong J; Amundadottir LT; Doki Y; Ishii H; Eguchi H; Bogumil D; Haiman CA; Le Marchand L; Mori M; Risch H; Setiawan VW; Tsugane S; Wakai K; Yoshida T; Matsuda F; Kubo M; Kikuchi S; Matsuo K
Nat Commun; 2020 Jun; 11(1):3175. PubMed ID: 32581250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
